Economic Affairs
-

"Sunshine" policy, named after one of Aesop's fables, has been the catch phrase of South Korea's appeasement policy toward North Korea to stimulate and restructure the already collapsed North Korean economy and eventually to convert North Korea to a more conciliatory and cooperative state.

After 10 years of shining the sunlight on North Korea, however, evidences that those self-imposed goals have been achieved are rather scarce. This suggests that, from the beginning, the basic premises of Sunshine policy must have been fatally incongruous with the reality: North Korea should not have been portrayed as an innocent traveler leisurely walking down the street. Or, perhaps, the policy toward North Korea should have pursued more serious goals than just stripping a man of his coat.

In this talk, Dr. Park proposes an alternative to the "Sunshine vs North Wind", and discusses the policy implications of his proposal.

For the past 14 years, Dr. Jongkyu Park has worked on various macroeconomic policy issues of Korean economy including economic forecasts, monetary policy, inflation, budget deficit, exchange rate, savings rate, population aging, real estate bubble, and Japan's economic slowdown and revival. He received B.A. in Economics from Seoul National University in Korea, M.S. in Statistics from University of North Carolina at Chapel Hill, and Ph.D. in Economics from Princeton University.

Philippines Conference Room

Shorenstein APARC
Stanford University
Encina Hall, Room E301
Stanford, CA 94305-6055

(650) 723-2408
0
DPP_0003.JPG PhD

For the past 14 years, Jongkyu Park has worked on various macroeconomic policy issues of Korean economy including economic forecasts, monetary policy, inflation, budget deficit, exchange rate, savings rate, population aging, realestate bubble, Japan's economic slowdown and revival, etc. He received B.A. in Economics from Seoul National University in Korea, M.S. in Statistics from University of North Carolina at Chapel Hill and Ph. D. in Economics from Princeton University.

Jongkyu Park Visiting Scholar Speaker Shorenstein Asia-Pacific Research Center
Seminars
-

Major economic reforms are often politically difficult.  They may cause pain to voters and provoke unrest.  They may be opposed by politicians whose time horizons are shortened by electoral cycles.  They may collide with the established ideology and long-standing practices of an entrenched ruling party.  They may be resisted by bureaucrats who fear change, and by vested interests with stakes in the status quo.  Obstacles to major economic reform can be daunting in democratic and autocratic polities alike. 

And yet, somehow, past leaders of today's Asian dragons did manage to get away with critical and creative economic reforms.  Sly political foxes nudged their countries onto high-growth paths toward global renown as economic dragons.  What lessons can be learned from their experiences?  Are tactics that worked in authoritarian systems applicable to democratic ones, and vice versa?  Can one identify a set of stratagems that would amount to an equivalent, for economic reformers, of the advice Machiavelli gave political princes? 

Arroyo will recount the crafty political maneuvers used by leaders of economic reform in Asia during these pivotal eras:  China under Deng Xiaoping; India in the 1990s; Thailand under General Prem Tinsulanonda; Vietnam's Doi Moi; South Korea under Park Chung Hee; Malaysia under Mahathir Mohamad; and Singapore under Lee Kuan Yew.  Arroyo's remarks will be drawn from the paper he has been writing at Stanford on "The Political Economy of Successful Reform: Asian Stratagems," which he describes as "a playbook of useful maneuvers for economic reformers."

Dennis Arroyo is presently on leave from his government post as a director of the National Economic and Development Authority (NEDA) of the Philippines.  He has held consultancies with the World Bank, the United Nations, and the survey research firm Social Weather Stations, and has written widely on socioeconomic topics.  His critique of the Philippine development plan won a mass media award for "best analysis."  He has degrees in economics from the University of the Philippines.  

Philippines Conference Room

0
Shorenstein APARC/Asia Foundation Visiting Fellow
Dennis.jpg

Dennis Arroyo is a corporate affiliate visiting fellow at Shorenstein APARC for 2007-08. Prior to joining Shorenstein APARC, he worked as the Director of National Planning and Policy Staff at the National Economic and Development Authority in the Philippines. Arroyo also formerly worked as a consultant for the World Bank in Washington DC and the World Bank office in Manila. Arroyo has spent much of his career in survey research with Social Weather Stations (SWS), which is a prominent organization in the World Association for Public Opinion Research (WAPOR).

Date Label
Dennis Arroyo 2007-2008 Shorenstein APARC/Asia Foundation Visiting Fellow Speaker Shorenstein APARC
Seminars
News Type
News
Date
Paragraphs

Shorenstein APARC is pleased to announce the winners of the 2008-09 Shorenstein Fellowship. Christian von Luebke and Li Han will join the center in fall 2008, each for a one-year term.

Dr. von Luebke completed his Ph.D. in 2007 in policy and governance at the Crawford School of Economics and Government, the Australian National University. He also holds a masters in Economics and a B.A. in Business and Political Science from Muenster University. He is currently working on a book that analyzes the determinants for local policy variation in Post-Suharto Indonesia. During his stay at the center, he will extend his work on local governance to other Asian transition countries, in particular China and the Philippines.

Li Han is currently a Ph.D. candidate at Harvard University. She expects to receive her Ph.D. in economics in June 2008. She also holds an M.A. in economics from Peking University and a B.A. from Xi'an Jiaotong University in China.

Li Han's primary fields are development economics and political economy. She is particularly interested in political incentives in nondemocracies and public policy issues in developing countries. She is currently working on a project that analyzes the link between economic liberalization and autocracies.

APARC looks forward to their arrival in the fall.

All News button
1
-
Teh-wei Hu is a Professor Emeritus of health economics at the University of California, Berkeley.  At Berkeley, he served as associate dean (1999-2002) and department chair (1990-1993) in the School of Public Health.  He received his PhD in Economics from the University of Wisconsin.  

During the past 40 years, Professor Hu has been teaching and conducting research in health economics, particularly in healthcare financing and the economics of tobacco control.  Hu was a Fulbright scholar in China. He has served as consultant or advisor to the World Bank, the World Health Organization, the National Institutes of Health, the Institute of Medicine, the Rand Corporation, the Ministry of Health in the People's Republic of China, Department of Health and Welfare in Hong Kong, Department of Health in the Republic of China (Taiwan), and many private research institutions and foundations. 

Professor Hu will speak to us immediately after an April trip to China, sharing his research and perspectives on the economics of tobacco control and the debate about healthcare system reforms in China (including a possible link between the two through financing expansions in coverage through increased tobacco taxation).

Philippines Conference Room

Teh-wei Hu Professor Emeritus Speaker University of California, Berkeley, School of Public Health
Seminars
Paragraphs

Modeling the government make-or-buy decision, Hart and colleagues [Hart, O., Shleifer, S. and Vishny, R.W., 1997, "The proper scope of government: Theory and an application to prisons", Quarterly Journal of Economics 112, 1127–1161] assume government providers are exogenously more replaceable than private providers. Instead, we posit government managers' soft incentives arise endogenously from their lack of control rights, because of rationally softer budget constraints.

All Publications button
1
Publication Type
Journal Articles
Publication Date
Journal Publisher
Economics Letters
Authors
Karen Eggleston
-

Conventional wisdom says that relations between China and Japan are fated always to be exceptionally wary, if not openly hostile -- and Japanese leaders' visits to the notorious Yasukuni have done nothing to undermine this view. Nor have Sino-Japanese standoffs over the disputed Senkaku islands. Meanwhile Beijing's opposition has been widely credited as the reason why Japan has failed in its reported aspiration to join the United Nations Security Council. Author and long-time Tokyo-based East Asia watcher Eamonn Fingleton argues that these issues have been grossly misunderstood in the West and that on closer inspection they say little if anything about the true state of Sino-Japanese relations. He insists that on a host of substantive issues overlooked by the press, Japan and China have been cooperating closely for decades. So much so that Japanese help has been one of the most powerful factors in China's rise.

A former editor for Forbes and the Financial Times, Eamonn Fingleton has been monitoring East Asian economics since 1985. He met China's supreme leader Deng Xiaoping in 1986 as a member of a New York Stock Exchange delegation. The following year he predicted the Tokyo banking crash and went on in Blindside, a controversial 1995 analysis that was praised by J.K. Galbraith and Bill Clinton, to show that a heedless America was fast losing its formerly vaunted leadership in advanced manufacturing to Japan.

His 1999 book In Praise of Hard Industries: Why Manufacturing, Not the Information Economy, Is the Key to Future Prosperity anticipated the American Internet stock crash of 2000. In his 2008 book In the Jaws of the Dragon: America's Fate in the Coming Era of Chinese Hegemony, he issues a strong challenge to the conventional view among Washington policymakers and think tank analysts that China is converging to Western economic and political forms and attitudes. His books have been read into the U.S. Senate record and named among the ten best business books of the year by Business Week and Amazon.com.

He was born in Ireland in 1948 and is a graduate of Trinity College Dublin. He was the recipient of the American Values Award from the United States Business and Industry Council in 2001.

Copies of Fingleton's newest book In the Jaws of the Dragon: America's Fate in the Coming Era of Chinese Hegemony - due March 4 by St. Martin's Press - will be for sale during the event.

Philippines Conference Room

Eamonn Fingleton author Speaker
Seminars
News Type
News
Date
Paragraphs

Since China joined the World Trade Organization (WTO) in 2001, its already cheap labor force has been exposed to global market competition. The country’s domestic employment situation, particularly with respect to guarantees of workers’ rights and interests, has likewise come under pressure. In the years from 1999 to 2002, recorded urban unemployment rates regularly increased, from 3.1 percent in 1999 and 2000, to 3.6 percent and 4.0 percent in 2001 and 2002, respectively. At the end of March 2003, they rose again to 4.1 percent. The number of labor disputes received by labor dispute arbitration committees at every level reached 184,000 by 2002, with the number of participating workers climbing to 610,000, numbers that were 19.1 percent and 30.2 percent higher, respectively, than the previous year. In short, while China’s participation in the WTO propelled economic development, trade system reform, adjustments to the economic structure, and privatization of enterprise, it also resulted in an uneasy state of affairs for labor and management relations. For instance, in October 2004, at Shenzhen’s Hong Kong-owned Meizhi Haiyan Electronics Factory, four thousand people went on strike and blockaded the roads to protest low wages.

In November 2004, amid concerns about deteriorating working conditions at foreign-funded enterprises, the All China Federation of Trade Unions (ACFTU) confronted Chinese locations of WalMart, which is well known for obstructing the establishment of trade unions. The ACFTU declared: “They [WalMart] are in violation of the Trade Union Law, and we are prepared to sue them.” WalMart yielded, conceding that, “[i]f workers ask to establish a trade union, we will respect that request, [and] fulfill our duties and responsibilities under the Trade Union Law.” This landmark event demonstrated not only the ACFTU’s power in a direct confrontation, but also its opposition to the intensifying WTO-driven competition in the Chinese labor market. Thus far, the power of trade unions in general and the ACFTU in particular has been felt primarily at foreign-funded enterprises. But what about locally owned and operated enterprises?

In order to understand the actual level of autonomy that trade unions enjoy at the grassroots level, the chairmen of 1,811 trade unions in major cities and provinces—including Liaoning, Beijing, Shanghai, Zhejiang, Guangdong, Gansu, Guizhou, and Henan—completed a questionnaire survey. The Chinese Institute of Industrial Relations (Beijing) facilitated the survey, which was carried out between March 2004 and June 2006. The major findings confirm that, although the independence of trade unions at foreign-funded enterprises has increased, the unions’ autonomy at local level enterprises remains fairly low. According to survey results, China continues to be a predominantly state-corporatist system, between the Chinese Communist Party (CCP) on the one hand and workers and state-owned/state-held enterprises on the other.

The survey revealed other data about the leadership of China’s state-owned/state-held enterprises. Most notably, the Party organization was still appointing 24.5 percent of the chairmen of these work units. Even in cases where chairmen assumed their posts through election or open selective examinations, 35.1 percent of them participated in the election or examinations after the Party recommended them to the work unit in question (see figure 1). The ratio of chairmen who are CCP members to those who serve concurrently as a “secretary,” “vice-secretary,” or member of the Party committee at a corresponding level reached high percentages, of 90.0 percent and 46.4 percent, respectively. In addition, 72.1 percent of the chairmen of state-owned/state-held enterprises answered in the survey that their union committee had established a Party group or Party branch at their workplace. These data clearly indicate that, unlike their counterparts at foreign-funded companies, the trade unions of state-owned/state-held enterprises not only lack autonomy, and but that their management also often remains subject to Party control.

All News button
1

In the pursuit to assess high-tech regions' performance in and capability for innovation and entrepreneurship, a bewildering variety of data is published, including:

  • employment
  • total corporate sales
  • wages
  • venture capital funding
  • new company formation and growth of small firms
  • R&D spending
  • patents, and many more

However, on the basis of such heterogeneous indicators, it can be difficult or even impossible to compare regions. Some of this is inevitable given different perceived data needs in each region. However, perhaps a common core of data might be supplied.

To this end, the Stanford Program on Regions of Innovation and Entrepreneurship is bringing together scholars and researchers from the United States, Europe and Asia to present data from their own regions that would help with comparisons between regions and linkages among them, and to make the case for what they consider the most useful set of indicators.

There will be four workshop sessions: the first will be devoted to discussing a framework for looking at entrepreneurship and innovation regional indicators, and the remaining three will take a regional focus, proposing indicators closely related to innovative regions in the United States, Europe and Asia.

This event is part of the "The Shape of Things to Come" conference at the Fisher Conference Center at Stanford University, January 17-18, 2007.

» Presentations/Papers from the event

Frances C. Arrillaga Alumni Center

Workshops
Paragraphs

Biotechnology (or biotech) has impacted almost every aspect of human life. It has reorganized industries, drastically changed healthcare, helped to improve the environment, and led to important changes in laws and ethical norms.

Among the various biotech fields, medical biotech has been by far the most influential, beneficial, and controversial. It has generated not only superlative discoveries to improve the lifespan and quality of human life, but also the greatest amount of wealth for all the players involved, and the greatest volume of public debate.

Several important trends are shaping the future of the pharmaceutical (or pharma) and biotech industries. The biotech industry is characterized by the presence of strong clusters in all countries. The pharma and biotech industries are experiencing an outsourcing phenomenon, mainly due to a lack of in-house expertise and efficiencies. Diagnostics and therapeutics are increasingly converging, a trend that will lead to predictive and precise diagnostics and personalized and preventive medicine. The first few years of the twenty-first century have witnessed significant changes in the pharma/biotech alliance landscape. Today we are seeing the “omic”-ization of the biotech industry: most of the emerging technologies are genomics, proteomics, cellomics, and pharmacogenomics. In addition, the biotech industry faces uphill ethical issues, including excessive marketing, third-world drug availability, genetic engineering, stem cells, and cloning.

The medical biotech industry faces several challenges. First, science, the human body, and disease are, essentially, complex. Second, unlike other high-technology industries, the biotech product development cycle is very long, even after proof of concept. Biotech projects take between ten and twenty years to become successful and cost over $200–300 million before a product reaches the market. Third, delivery of most biotech products and therapies is complex and can be painful, often involving intravenous delivery. Fourth, the preceding three factors pose significant challenges for research and development (R&D) financing. In addition, there are certain outside determinants that influence the biotech industry, including regulation, demography, reimbursement climate, and big pharma companies.

Stem cell research is one of the most fascinating areas of biology, but it raises questions as rapidly as it generates new discoveries. The greatest potential application of this research is the generation of cells and tissues that can be used for cell-based therapies. A stem cell is a special kind of cell that has a unique capacity to renew itself and to give rise to specialized cell types. Through the process of differentiation, stem cells form various tissues and organs, and the combination of these differentiated materials develops into the whole human body. This class of human stem cell holds the promise of being able to repair or replace cells or tissues that are damaged or destroyed by many of our most devastating diseases.

Diabetes mellitus is a group of diseases characterized by high levels of blood glucose resulting from defects in insulin production, insulin action, or both. Diabetes mellitus is a type I diabetes—also called juvenile-onset diabetes or insulin-dependent diabetes—and develops when the body’s immune system destroys pancreatic beta cells, the only cells in the body that make the insulin that regulates blood glucose. Type II diabetes, also called adult-onset diabetes or noninsulin-dependent diabetes, may account for 90–95 percent of all diagnosed cases of diabetes. There are more than 194 million diabetics worldwide, with this number expected to exceed 333 million by 2025.

Insulin is currently the most effective drug for controlling hyperglycemia and is widely accepted as the gold standard for treating type I diabetes and even late-stage type II diabetes. However, physicians and patients are reluctant to use insulin until other less effective drugs have been attempted. This is mainly because insulin therapy is invasive and painful: patients must take insulin intravenously.

One of the most promising ways to cure diabetes is to restore the function of islet cells biologically, either through islet cell transplantation or by engineering cells to restore the insulin secreting function. Islet transplantation, a procedure that can restore insulin production in patients, is a highly promising area of research.

Based on analysis of stem cell research, diabetes market opportunities, and the development of stem cell therapies, it is possible to place a value on a company in the early (preclinical) development stage of a stem cell therapy for diabetes. Such an exercise involves valuing a company based on three different approaches—(1) the discounted cashflow model, (2) the royalty or licensing model, and (3) the comparables valuation model. Sensitivity analysis based on market, pricing, costing, R&D, and development stage can further lead to precise valuation range for a given company.

For biotechnology companies, various drivers play a critical role in company valuation, including people (management team), alliances and partnerships, intellectual property rights, R&D and technology, funding and financing, market opportunity, and therapeutic area.

All Publications button
1
Publication Type
Working Papers
Publication Date
Journal Publisher
Shorenstein APARC
Authors
Subscribe to Economic Affairs